Skip to content
Citation only via Europe PMC

Cycloastragenol extends lifespan and enhances stress resistance in Caenorhabditis elegans by inhibiting IIS pathway and activating p38 MAPK-mediated innate immunity.

Feng C, Zhang X, Zhao T, Shi T, Zhao P, Wang M, Ren J, Xu K, Yao J, Zhang L, Yin X, Xia X.

European journal of pharmacology · 2026

Abstract

Aging is a complex physiological process characterized by progressive functional decline, yet effective pharmacological interventions from medicine-food homologous sources remain limited. While Cycloastragenol (CAG), a bioactive triterpenoid from Astragalus membranaceus, is known for telomerase activation, its non-telomeric mechanisms require elucidation. This study investigated the longevity-promoting effects of CAG using the Caenorhabditis elegans model, identifying 0.2 μM as the optimal concentration that extended mean lifespan by 30.64%. Beyond longevity, CAG treatment significantly ameliorated aging-associated phenotypes, including enhanced locomotion, reduced lipofuscin accumulation, improved stress resistance, and strengthened immunity against Pseudomonas aeruginosa. Mechanistic analyses revealed that CAG promotes nuclear translocation of the FOXO transcription factor DAF-16 and elevates antioxidant enzyme activities. Crucially, using specific mutant strains and gene expression profiling, we provide the first evidence that CAG extends healthspan(definition) through a telomerase-independent mechanism involving the simultaneous inhibition of the Insulin/IGF-1 Signaling (IIS) pathway and activation of the p38 MAPK (SEK-1/PMK-1/SKN-1) axis. This study establishes a novel link between CAG-mediated innate immune enhancement and longevity, distinguishing its mode of action from previous telomere(definition)-centric models. These findings clarify the pharmacological basis of CAG and support its potential development as a safe therapeutic agent for age-related disorders.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1016/j.ejphar.2026.179325
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
C, F., X, Z., T, Z., T, S., P, Z., M, W., J, R., K, X., J, Y., L, Z., X, Y., &amp; X., X. (2026). Cycloastragenol extends lifespan and enhances stress resistance in Caenorhabditis elegans by inhibiting IIS pathway and activating p38 MAPK-mediated innate immunity. <em>European journal of pharmacology</em>. https://doi.org/10.1016/j.ejphar.2026.179325
Vancouver
C F, X Z, T Z, T S, P Z, M W, et al. Cycloastragenol extends lifespan and enhances stress resistance in Caenorhabditis elegans by inhibiting IIS pathway and activating p38 MAPK-mediated innate immunity. European journal of pharmacology. 2026. doi:10.1016/j.ejphar.2026.179325.
BibTeX
@article{feng2026Cycloa, title = {Cycloastragenol extends lifespan and enhances stress resistance in Caenorhabditis elegans by inhibiting IIS pathway and activating p38 MAPK-mediated innate immunity.}, author = {Feng C and Zhang X and Zhao T and Shi T and Zhao P and Wang M and Ren J and Xu K and Yao J and Zhang L and Yin X and Xia X.}, journal = {European journal of pharmacology}, year = {2026}, doi = {10.1016/j.ejphar.2026.179325}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings